118 related articles for article (PubMed ID: 26998084)
1. Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.
Ou Y; Xia R; Kong F; Zhang X; Yu S; Jiang L; Zheng L; Lin L
Oncol Lett; 2016 Mar; 11(3):1823-1828. PubMed ID: 26998084
[TBL] [Abstract][Full Text] [Related]
2. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
3. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
4. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
[TBL] [Abstract][Full Text] [Related]
5. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
6. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
7. The role of DEK protein in hepatocellular carcinoma for progression and prognosis.
Lin LJ; Chen LT
Pak J Med Sci; 2013 May; 29(3):778-82. PubMed ID: 24353627
[TBL] [Abstract][Full Text] [Related]
8. Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis.
Zhao T; Qiu B; Zhou S; Ding G; Cao L; Wu Z
J Cancer; 2019; 10(4):911-917. PubMed ID: 30854097
[No Abstract] [Full Text] [Related]
9. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
[TBL] [Abstract][Full Text] [Related]
10. DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression.
Yang MQ; Bai LL; Wang Z; Lei L; Zheng YW; Li ZH; Huang WJ; Liu CC; Xu HT
Oncol Lett; 2021 Jun; 21(6):440. PubMed ID: 33868478
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
12. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
13. High expression of integrin-linked kinase predicts aggressiveness and poor prognosis in patients with gastric cancer.
Gu X; Xing X; Yang W; Hu J; Dai D
Acta Histochem; 2014 Jun; 116(5):758-62. PubMed ID: 24502999
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma.
Li DX; Cai HY; Wang X; Feng YL; Cai SW
Exp Ther Med; 2014 Sep; 8(3):844-850. PubMed ID: 25120612
[TBL] [Abstract][Full Text] [Related]
17. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
19. [HBXIP expression in gastric adenocarcinoma predicts poor prognosis].
Piao JJ; Li N; Wang YX; Lin ZH; Liu SP
Zhonghua Bing Li Xue Za Zhi; 2017 Feb; 46(2):88-92. PubMed ID: 28173666
[No Abstract] [Full Text] [Related]
20. DEK: A novel early screening and prognostic marker for breast cancer.
Ying G; Wu Y
Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
